- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Dry Powder Inhaler Device will have significant change from previous year. By the most conservative estimates of global Dry Powder Inhaler Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 733.5 million in 2020. Over the next five years the Dry Powder Inhaler Device market will register a 5.1% CAGR in terms of revenue, the global market size will reach US$ 894.4 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhaler Device market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Single Dose
Multi-dose
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Asthma
COPD
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Mylan
Novartis
Schering/Merck
Teva
Vectura
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Dry Powder Inhaler Device Consumption 2016-2026
2.1.2 Dry Powder Inhaler Device Consumption CAGR by Region
2.2 Dry Powder Inhaler Device Segment by Type
2.2.1 Single Dose
2.2.2 Multi-dose
2.3 Dry Powder Inhaler Device Sales by Type
2.3.1 Global Dry Powder Inhaler Device Sales Market Share by Type (2016-2021)
2.3.2 Global Dry Powder Inhaler Device Revenue and Market Share by Type (2016-2021)
2.3.3 Global Dry Powder Inhaler Device Sale Price by Type (2016-2021)
2.4 Dry Powder Inhaler Device Segment by Application
2.4.1 Asthma
2.4.2 COPD
2.4.3 Others
2.5 Dry Powder Inhaler Device Sales by Application
2.5.1 Global Dry Powder Inhaler Device Sale Market Share by Application (2016-2021)
2.5.2 Global Dry Powder Inhaler Device Revenue and Market Share by Application (2016-2021)
2.5.3 Global Dry Powder Inhaler Device Sale Price by Application (2016-2021)
3 Global Dry Powder Inhaler Device by Company
3.1 Global Dry Powder Inhaler Device Sales Market Share by Company
3.1.1 Global Dry Powder Inhaler Device Sales by Company (2019-2021)
3.1.2 Global Dry Powder Inhaler Device Sales Market Share by Company (2019-2021)
3.2 Global Dry Powder Inhaler Device Revenue Market Share by Company
3.2.1 Global Dry Powder Inhaler Device Revenue by Company (2019-2021)
3.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Company (2019-2021)
3.3 Global Dry Powder Inhaler Device Sale Price by Company
3.4 Global Manufacturers Dry Powder Inhaler Device Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dry Powder Inhaler Device Product Location Distribution
3.4.2 Players Dry Powder Inhaler Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Dry Powder Inhaler Device by Region
4.1 Global Dry Powder Inhaler Device by Region
4.1.1 Global Dry Powder Inhaler Device Sales by Region
4.1.2 Global Dry Powder Inhaler Device Revenue by Region
4.2 Americas Dry Powder Inhaler Device Sales Growth
4.3 APAC Dry Powder Inhaler Device Sales Growth
4.4 Europe Dry Powder Inhaler Device Sales Growth
4.5 Middle East & Africa Dry Powder Inhaler Device Sales Growth
5 Americas
5.1 Americas Dry Powder Inhaler Device Sales by Country
5.1.1 Americas Dry Powder Inhaler Device Sales by Country (2016-2021)
5.1.2 Americas Dry Powder Inhaler Device Revenue by Country (2016-2021)
5.2 Americas Dry Powder Inhaler Device Sales by Type
5.3 Americas Dry Powder Inhaler Device Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dry Powder Inhaler Device Sales by Region
6.1.1 APAC Dry Powder Inhaler Device Sales by Region (2016-2021)
6.1.2 APAC Dry Powder Inhaler Device Revenue by Region (2016-2021)
6.2 APAC Dry Powder Inhaler Device Sales by Type
6.3 APAC Dry Powder Inhaler Device Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Dry Powder Inhaler Device by Country
7.1.1 Europe Dry Powder Inhaler Device Sales by Country (2016-2021)
7.1.2 Europe Dry Powder Inhaler Device Revenue by Country (2016-2021)
7.2 Europe Dry Powder Inhaler Device Sales by Type
7.3 Europe Dry Powder Inhaler Device Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Dry Powder Inhaler Device by Country
8.1.1 Middle East & Africa Dry Powder Inhaler Device Sales by Country (2016-2021)
8.1.2 Middle East & Africa Dry Powder Inhaler Device Revenue by Country (2016-2021)
8.2 Middle East & Africa Dry Powder Inhaler Device Sales by Type
8.3 Middle East & Africa Dry Powder Inhaler Device Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Dry Powder Inhaler Device Distributors
10.3 Dry Powder Inhaler Device Customer
11 Global Dry Powder Inhaler Device Market Forecast
11.1 Global Dry Powder Inhaler Device Forecast by Region
11.1.1 Global Dry Powder Inhaler Device Forecast by Regions (2021-2026)
11.2.2 Global Dry Powder Inhaler Device Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Dry Powder Inhaler Device Forecast by Type
11.7 Global Dry Powder Inhaler Device Forecast by Application
12 Key Players Analysis
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Information
12.1.2 GlaxoSmithKline Dry Powder Inhaler Device Product Offered
12.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 GlaxoSmithKline Main Business Overview
12.1.5 GlaxoSmithKline Latest Developments
12.2 AstraZeneca
12.2.1 AstraZeneca Company Information
12.2.2 AstraZeneca Dry Powder Inhaler Device Product Offered
12.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 AstraZeneca Main Business Overview
12.2.5 AstraZeneca Latest Developments
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Company Information
12.3.2 Boehringer Ingelheim Dry Powder Inhaler Device Product Offered
12.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Boehringer Ingelheim Main Business Overview
12.3.5 Boehringer Ingelheim Latest Developments
12.4 Chiesi
12.4.1 Chiesi Company Information
12.4.2 Chiesi Dry Powder Inhaler Device Product Offered
12.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Chiesi Main Business Overview
12.4.5 Chiesi Latest Developments
12.5 Cipla
12.5.1 Cipla Company Information
12.5.2 Cipla Dry Powder Inhaler Device Product Offered
12.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Cipla Main Business Overview
12.5.5 Cipla Latest Developments
12.6 3M
12.6.1 3M Company Information
12.6.2 3M Dry Powder Inhaler Device Product Offered
12.6.3 3M Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 3M Main Business Overview
12.6.5 3M Latest Developments
12.7 Hovione
12.7.1 Hovione Company Information
12.7.2 Hovione Dry Powder Inhaler Device Product Offered
12.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Hovione Main Business Overview
12.7.5 Hovione Latest Developments
12.8 Mannkind
12.8.1 Mannkind Company Information
12.8.2 Mannkind Dry Powder Inhaler Device Product Offered
12.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Mannkind Main Business Overview
12.8.5 Mannkind Latest Developments
12.9 Mylan
12.9.1 Mylan Company Information
12.9.2 Mylan Dry Powder Inhaler Device Product Offered
12.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Mylan Main Business Overview
12.9.5 Mylan Latest Developments
12.10 Novartis
12.10.1 Novartis Company Information
12.10.2 Novartis Dry Powder Inhaler Device Product Offered
12.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Novartis Main Business Overview
12.10.5 Novartis Latest Developments
12.11 Schering/Merck
12.11.1 Schering/Merck Company Information
12.11.2 Schering/Merck Dry Powder Inhaler Device Product Offered
12.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Schering/Merck Main Business Overview
12.11.5 Schering/Merck Latest Developments
12.12 Teva
12.12.1 Teva Company Information
12.12.2 Teva Dry Powder Inhaler Device Product Offered
12.12.3 Teva Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Teva Main Business Overview
12.12.5 Teva Latest Developments
12.13 Vectura
12.13.1 Vectura Company Information
12.13.2 Vectura Dry Powder Inhaler Device Product Offered
12.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Vectura Main Business Overview
12.13.5 Vectura Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Dry Powder Inhaler Device Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Single Dose
Table 3. Major Players of Multi-dose
Table 4. Global Dry Powder Inhaler Device Sales by Type (2016-2021) & (K Units)
Table 5. Global Dry Powder Inhaler Device Sales Market Share by Type (2016-2021)
Table 6. Global Dry Powder Inhaler Device Revenue by Type (2016-2021) & ($ million)
Table 7. Global Dry Powder Inhaler Device Revenue Market Share by Type (2016-2021)
Table 8. Global Dry Powder Inhaler Device Sale Price by Type (2016-2021)
Table 9. Global Dry Powder Inhaler Device Sales by Application (2016-2021) & (K Units)
Table 10. Global Dry Powder Inhaler Device Sales Market Share by Application (2016-2021)
Table 11. Global Dry Powder Inhaler Device Value by Application (2016-2021)
Table 12. Global Dry Powder Inhaler Device Revenue Market Share by Application (2016-2021)
Table 13. Global Dry Powder Inhaler Device Sale Price by Application (2016-2021)
Table 14. Global Dry Powder Inhaler Device Sales by Company (2019-2021) & (K Units)
Table 15. Global Dry Powder Inhaler Device Sales Market Share by Company (2019-2021)
Table 16. Global Dry Powder Inhaler Device Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Dry Powder Inhaler Device Revenue Market Share by Company (2019-2021)
Table 18. Global Dry Powder Inhaler Device Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Dry Powder Inhaler Device Producing Area Distribution and Sales Area
Table 20. Players Dry Powder Inhaler Device Products Offered
Table 21. Dry Powder Inhaler Device Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Dry Powder Inhaler Device Sales by Region (2016-2021) (K Units)
Table 25. Global Dry Powder Inhaler Device Sales Market Share by Region (2016-2021)
Table 26. Global Dry Powder Inhaler Device Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Dry Powder Inhaler Device Revenue Market Share by Region (2016-2021)
Table 28. Americas Dry Powder Inhaler Device Sales by Country (2016-2021) & (K Units)
Table 29. Americas Dry Powder Inhaler Device Sales Market Share by Country (2016-2021)
Table 30. Americas Dry Powder Inhaler Device Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Dry Powder Inhaler Device Revenue Market Share by Country (2016-2021)
Table 32. Americas Dry Powder Inhaler Device Sales by Type (2016-2021) & (K Units)
Table 33. Americas Dry Powder Inhaler Device Sales Market Share by Type (2016-2021)
Table 34. Americas Dry Powder Inhaler Device Sales by Application (2016-2021) & (K Units)
Table 35. Americas Dry Powder Inhaler Device Sales Market Share by Application (2016-2021)
Table 36. APAC Dry Powder Inhaler Device Sales by Region (2016-2021) & (K Units)
Table 37. APAC Dry Powder Inhaler Device Sales Market Share by Region (2016-2021)
Table 38. APAC Dry Powder Inhaler Device Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Dry Powder Inhaler Device Revenue Market Share by Region (2016-2021)
Table 40. APAC Dry Powder Inhaler Device Sales by Type (2016-2021) & (K Units)
Table 41. APAC Dry Powder Inhaler Device Sales Market Share by Type (2016-2021)
Table 42. APAC Dry Powder Inhaler Device Sales by Application (2016-2021) & (K Units)
Table 43. APAC Dry Powder Inhaler Device Sales Market Share by Application (2016-2021)
Table 44. Europe Dry Powder Inhaler Device Sales by Country (2016-2021) & (K Units)
Table 45. Europe Dry Powder Inhaler Device Sales Market Share by Country (2016-2021)
Table 46. Europe Dry Powder Inhaler Device Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Dry Powder Inhaler Device Revenue Market Share by Country (2016-2021)
Table 48. Europe Dry Powder Inhaler Device Sales by Type (2016-2021) & (K Units)
Table 49. Europe Dry Powder Inhaler Device Sales Market Share by Type (2016-2021)
Table 50. Europe Dry Powder Inhaler Device Sales by Application (2016-2021) & (K Units)
Table 51. Europe Dry Powder Inhaler Device Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Dry Powder Inhaler Device Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Dry Powder Inhaler Device Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Dry Powder Inhaler Device Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Dry Powder Inhaler Device Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Dry Powder Inhaler Device Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Dry Powder Inhaler Device Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Dry Powder Inhaler Device Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Dry Powder Inhaler Device Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Dry Powder Inhaler Device
Table 61. Key Application and Potential Industries of Dry Powder Inhaler Device
Table 62. Key Challenges of Dry Powder Inhaler Device
Table 63. Key Trends of Dry Powder Inhaler Device
Table 64. Dry Powder Inhaler Device Distributors List
Table 65. Dry Powder Inhaler Device Customer List
Table 66. Global Dry Powder Inhaler Device Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Dry Powder Inhaler Device Consumption Market Forecast by Region
Table 68. Global Dry Powder Inhaler Device Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Dry Powder Inhaler Device Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Dry Powder Inhaler Device Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Dry Powder Inhaler Device Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Dry Powder Inhaler Device Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Dry Powder Inhaler Device Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Dry Powder Inhaler Device Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Dry Powder Inhaler Device Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Dry Powder Inhaler Device Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Dry Powder Inhaler Device Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Dry Powder Inhaler Device Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Dry Powder Inhaler Device Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Dry Powder Inhaler Device Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Dry Powder Inhaler Device Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Dry Powder Inhaler Device Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Dry Powder Inhaler Device Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Dry Powder Inhaler Device Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Dry Powder Inhaler Device Revenue Market Share Forecast by Application (2021-2026)
Table 86. GlaxoSmithKline Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 87. GlaxoSmithKline Dry Powder Inhaler Device Product Offered
Table 88. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 89. GlaxoSmithKline Main Business
Table 90. GlaxoSmithKline Latest Developments
Table 91. AstraZeneca Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 92. AstraZeneca Dry Powder Inhaler Device Product Offered
Table 93. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 94. AstraZeneca Main Business
Table 95. AstraZeneca Latest Developments
Table 96. Boehringer Ingelheim Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 97. Boehringer Ingelheim Dry Powder Inhaler Device Product Offered
Table 98. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 99. Boehringer Ingelheim Main Business
Table 100. Boehringer Ingelheim Latest Developments
Table 101. Chiesi Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 102. Chiesi Dry Powder Inhaler Device Product Offered
Table 103. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 104. Chiesi Main Business
Table 105. Chiesi Latest Developments
Table 106. Cipla Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 107. Cipla Dry Powder Inhaler Device Product Offered
Table 108. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 109. Cipla Main Business
Table 110. Cipla Latest Developments
Table 111. 3M Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 112. 3M Dry Powder Inhaler Device Product Offered
Table 113. 3M Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 114. 3M Main Business
Table 115. 3M Latest Developments
Table 116. Hovione Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 117. Hovione Dry Powder Inhaler Device Product Offered
Table 118. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 119. Hovione Main Business
Table 120. Hovione Latest Developments
Table 121. Mannkind Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 122. Mannkind Dry Powder Inhaler Device Product Offered
Table 123. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 124. Mannkind Main Business
Table 125. Mannkind Latest Developments
Table 126. Mylan Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 127. Mylan Dry Powder Inhaler Device Product Offered
Table 128. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 129. Mylan Main Business
Table 130. Mylan Latest Developments
Table 131. Novartis Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 132. Novartis Dry Powder Inhaler Device Product Offered
Table 133. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 134. Novartis Main Business
Table 135. Novartis Latest Developments
Table 136. Schering/Merck Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 137. Schering/Merck Dry Powder Inhaler Device Product Offered
Table 138. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 139. Schering/Merck Main Business
Table 140. Schering/Merck Latest Developments
Table 141. Teva Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 142. Teva Dry Powder Inhaler Device Product Offered
Table 143. Teva Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 144. Teva Main Business
Table 145. Teva Latest Developments
Table 146. Vectura Basic Information, Dry Powder Inhaler Device Manufacturing Base, Sales Area and Its Competitors
Table 147. Vectura Dry Powder Inhaler Device Product Offered
Table 148. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 149. Vectura Main Business
Table 150. Vectura Latest Developments
List of Figures
Figure 1. Picture of Dry Powder Inhaler Device
Figure 2. Dry Powder Inhaler Device Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dry Powder Inhaler Device Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Dry Powder Inhaler Device Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Dry Powder Inhaler Device Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Single Dose
Figure 10. Product Picture of Multi-dose
Figure 11. Global Dry Powder Inhaler Device Sales Market Share by Type in 2020
Figure 12. Global Dry Powder Inhaler Device Revenue Market Share by Type (2016-2021)
Figure 13. Dry Powder Inhaler Device Consumed in Asthma
Figure 14. Global Dry Powder Inhaler Device Market: Asthma (2016-2021) & (K Units)
Figure 15. Dry Powder Inhaler Device Consumed in COPD
Figure 16. Global Dry Powder Inhaler Device Market: COPD (2016-2021) & (K Units)
Figure 17. Dry Powder Inhaler Device Consumed in Others
Figure 18. Global Dry Powder Inhaler Device Market: Others (2016-2021) & (K Units)
Figure 19. Global Dry Powder Inhaler Device Sales Market Share by Application (2016-2021)
Figure 20. Global Dry Powder Inhaler Device Revenue Market Share by Application in 2020
Figure 21. Dry Powder Inhaler Device Revenue Market by Company in 2020 ($ Million)
Figure 22. Global Dry Powder Inhaler Device Revenue Market Share by Company in 2020
Figure 23. Global Dry Powder Inhaler Device Sales Market Share by Regions (2016-2021)
Figure 24. Global Dry Powder Inhaler Device Revenue Market Share by Region in 2020
Figure 25. Americas Dry Powder Inhaler Device Sales 2016-2021 (K Units)
Figure 26. Americas Dry Powder Inhaler Device Revenue 2016-2021 ($ Millions)
Figure 27. APAC Dry Powder Inhaler Device Sales 2016-2021 (K Units)
Figure 28. APAC Dry Powder Inhaler Device Revenue 2016-2021 ($ Millions)
Figure 29. Europe Dry Powder Inhaler Device Sales 2016-2021 (K Units)
Figure 30. Europe Dry Powder Inhaler Device Revenue 2016-2021 ($ Millions)
Figure 31. Middle East & Africa Dry Powder Inhaler Device Sales 2016-2021 (K Units)
Figure 32. Middle East & Africa Dry Powder Inhaler Device Revenue 2016-2021 ($ Millions)
Figure 33. Americas Dry Powder Inhaler Device Sales Market Share by Country in 2020
Figure 34. Americas Dry Powder Inhaler Device Revenue Market Share by Country in 2020
Figure 35. Americas Dry Powder Inhaler Device Sales Market Share by Type in 2020
Figure 36. Americas Dry Powder Inhaler Device Sales Market Share by Application in 2020
Figure 37. United States Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 38. Canada Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 39. Mexico Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 40. Brazil Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 41. APAC Dry Powder Inhaler Device Sales Market Share by Region in 2020
Figure 42. APAC Dry Powder Inhaler Device Revenue Market Share by Regions in 2020
Figure 43. APAC Dry Powder Inhaler Device Sales Market Share by Type in 2020
Figure 44. APAC Dry Powder Inhaler Device Sales Market Share by Application in 2020
Figure 45. China Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 46. Japan Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 47. Korea Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 48. Southeast Asia Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 49. India Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 50. Australia Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 51. Europe Dry Powder Inhaler Device Sales Market Share by Country in 2020
Figure 52. Europe Dry Powder Inhaler Device Revenue Market Share by Country in 2020
Figure 53. Europe Dry Powder Inhaler Device Sales Market Share by Type in 2020
Figure 54. Europe Dry Powder Inhaler Device Sales Market Share by Application in 2020
Figure 55. Germany Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 56. France Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 57. UK Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 58. Italy Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 59. Russia Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 60. Middle East & Africa Dry Powder Inhaler Device Sales Market Share by Country in 2020
Figure 61. Middle East & Africa Dry Powder Inhaler Device Revenue Market Share by Country in 2020
Figure 62. Middle East & Africa Dry Powder Inhaler Device Sales Market Share by Type in 2020
Figure 63. Middle East & Africa Dry Powder Inhaler Device Sales Market Share by Application in 2020
Figure 64. Egypt Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 65. South Africa Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 66. Israel Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 67. Turkey Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 68. GCC Country Dry Powder Inhaler Device Revenue Growth 2016-2021 ($ Millions)
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
